Inventaire - your friends and communities are your best library

Prevention of cervical cancer through papillomavirus vaccination

এতে প্রকাশিত: Nature Reviews Immunology

তারিখে প্রকাশিত: 2004-01-01

মূল বিষয়: জরায়ুমুখের ক্যান্সার

Cites articles 63

তারিখ

শিরোনাম

লেখকগণ

2004-03-01

Mutations in TAP genes are common in cervical carcinomas.

Ian Frazer
2003-02-06

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Francesc Xavier Bosch José, Xavier Castellsagué, Peter J F Snijders
2003-09-01

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.

Robert W. Platt, Eduardo L. Franco
2003-10-01

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

Eduardo L. Franco, Milton Weinstein, Sue Goldie
2003-08-01

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin

Merilyn Hibma, John Doorbar
2003-08-01

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

Allan Hildesheim
2003-06-01

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection
2003-07-01

Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes

William R Heath, Masaru Okabe
2003-11-01

IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host,IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host

Germain J.P. Fernando
2003-04-01

Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA

Joseph A Politch, Mary Lynne Hedley
2003-07-30

Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients

Michael Pawlita
2002-11-01

A controlled trial of a human papillomavirus type 16 vaccine

Cosette M Wheeler, Kathrin Jansen, Laura Koutsky
2002-04-01

The causal relation between human papillomavirus and cervical cancer

Francesc Xavier Bosch José
2002-01-01

Immune evasion in human papillomavirus-associated cervical cancer
2002-11-01

Animal models of papillomavirus pathogenesis
2002-03-01

Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells
2002-04-01

Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions

Ian Frazer
2002-10-01

Life cycle heterogeneity in animal models of human papillomavirus-associated disease

Kiyofumi Egawa
2002-07-01

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

Cornelis J. M. Melief, Sjoerd H van der Burg
2002-10-01

Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide

Graham R. Leggatt, Ian Frazer
2002-10-01

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

Annemieke De Jong
2002-04-01

Activity of HspE7, a novel immunotherapy, in patients with anogenital warts
2001-05-01

Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes

Matthias Nees
2001-04-01

Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes.
2001-02-01

Immunological analyses of human papillomavirus capsids
2001-04-01

A fresh look at tumor immunosurveillance and immunotherapy

মার্ক জে স্মিথ, Dale I Godfrey, Joseph A Trapani
2001-10-29

Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.
2001-10-01

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site
2001-12-01

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im
2001-03-01

Therapeutic potential of protein and adjuvant vaccinations on tumour growth

Yvonne Paterson
2001-12-01

Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure
2001-11-01

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

Leszek Borysiewicz

নিবন্ধ - wd:Q35620080

জায়ে আপনাকে স্বাগত

the library of your friends and communities

আরো জানুন